Diagnosis and management of adult telomere biology disorders
Telomere biology disorders (TBD) comprise a heterogenous group of inherited conditions characterized by impaired telomere maintenance, resulting in abnormal telomere lengths and/or telomere dysfunction. The clinical spectrum of TBD is broad, spanning bone marrow failure, pulmonary fibrosis, liver disease, and an increased predisposition to malignancy, complicating timely diagnosis and management. In this review, we explore the evolving clinical landscape and diagnostic strategies for TBD, while highlighting the diverse phenotypic presentations. We further examine the role of telomere dysfunction in driving cancer development and clonal hematopoiesis. Finally, we discuss current and emerging therapeutic approaches for TBD, emphasizing the need for individualized and multidisciplinary management to optimize patients' outcomes.
Authors
- Madeline Franke (ORCID: https://orcid.org/0000-0002-9573-3607)
- Mrinal M. Patnaik (ORCID: https://orcid.org/0000-0001-6998-662X)
- Alejandro Tiana Ferrer
Institutions
- Mayo Clinic (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Haematologica
- Published
- 2025-10-02
- DOI
- https://doi.org/10.3324/haematol.2025.287739
- Primary Topic
- Telomeres, Telomerase, and Senescence
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca
- Swedish Orphan Biovitrum
- Center for Individualized Medicine, Mayo Clinic